title: Development of radiation therapy optimization.
abstract: The principal radiobiological problems in the treatment of advanced tumors and the solution of many of them by radiobiologically optimized intensity-modulated radiation therapy are presented. Considerable improvements of the treatment outcome using radiobiologically optimized intensity-modulated treatments are achieved by: (a) increasing the tumor dose and dose per fraction; (b) keeping constant or even reducing slightly the dose and dose per fraction to organs at risk, (c) reducing the overall treatment time and the number of treatment fractions. The merits of the new radiation modalities and advanced intensity-modulated treatment techniques are compared in terms of equipment costs per patient cured. It is predicted that the new development of radiobiologically optimized intensity-modulated radiation therapy will rapidly become an important clinical tool, increasing the efficiency of the collaboration between radiation physicists, radiation biologists and radiation oncologists. Not only does it allow the optimal treatment of every patient, but it also promotes an efficient feedback of treatment outcome and complication data to improve the accuracy of known dose response relations to further augment future treatment results. Equipment costs may go up during a transition period until efficient interfaces between new diagnostic equipment, treatment-planning systems and intensity-modulated treatment units are fully developed. From then onwards the cost of high quality biologically optimized intensity-modulated treatments will decrease and so will the treatment time and personnel requirements, at the same time as the treatment quality is greatly improved particularly for more advanced tumors.
authors.affiliation: Department of Medical Radiation Physics, Karolinska Institutet and Stockholm University, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Brahme
mesh_terms: D019583:Dose Fractionation, Radiation; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011379:Prognosis; D011785:Quality Assurance, Health Care; D011853:Radiobiology; D011878:Radiotherapy / Q000191:economics / Q000379:methods / Q000639:trends*; D012307:Risk Factors